[Brokerage Focus] Guozheng International: Innovative drug companies and medical instruments companies are expected to continuously expand their market ceiling by going overseas.

Jinwu Financial News | Guozheng International reports that looking ahead to 2025, as the Federal Reserve begins a rate-cutting cycle, combined with the high premium rate of AH shares making Hong Kong stocks more cost-effective, liquidity in the Hong Kong stock market is expected to improve. For the Medical Device Sector, driven by the continuous promotion of the "medical insurance + commercial insurance" model and policy support, the scale of the Industry is expected to further expand. The bank is Bullish on three main investment themes: 1. Innovation: Innovative Drugs and Medical Devices, which are sensitive to interest rates, are expected to continue benefiting from the improvement in liquidity. The bank believes that the main factors driving the development of Innovative Drugs in 2025 are as follows: (1) Going global. Due to the price differences between China and the United States.

Jingwu Financial NewsDec 17 14:15

Tempus hold (06880) plans to implement a restructuring.

Tempus hold (06880) announced that on November 4, 2024, the company (as the borrower), jointly...

Zhitong FinanceDec 6 23:01

Tempus hold (06880) and its professional advisors are preparing for the review by the Listing Review Committee.

Tempus hold (06880) issued an announcement that on the date of this announcement, the company and its professional advisors are working for the listing review committee...

Zhitong FinanceDec 4 22:33

tempus hold (06880.HK): The court hearing is scheduled to continue the suspension on January 23, 2025.

Grain 12th of December, Tempus Hold (06880.HK) announced that on November 4, 2024, in accordance with Article 670 of the Company Ordinance (Chapter 622 of the Laws of Hong Kong), they have applied to the High Court of Hong Kong for an order to convene a meeting of the company's bondholders to consider and approve (with or without modification) the proposed debt repayment arrangement plan. A court hearing is scheduled for January 23, 2025. The company will timely issue another announcement to inform its shareholders and potential investors of the latest developments. The trading of shares remains suspended.

Gelonghui FinanceDec 4 22:32

Tempus Holdings Narrows Loss in H1

MT NewswiresNov 20 14:05

TEMPUS HOLD: Interim Report 2024

HKEXNov 19 22:57 · Announcements